Skip to content
You are now leaving to visit

Akcea and Ionis Announce Approval of TEGSEDI™ (inotersen) in the European Union

CAMBRIDGE, Mass. and CARLSBAD, Calif., July 11, 2018 (GLOBE NEWSWIRE) — Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc. , and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), announced today that TEGSEDI TM (inotersen) has received marketing authorization approval